Department of Medicine Hematology-Oncology, UVM Medical Center, Burlington, VT, USA.
Department of Pathology and Laboratory Medicine, U-VM Larner College of Medicine, Burlington, VT, USA.
Cancer Genet. 2022 Jan;260-261:30-36. doi: 10.1016/j.cancergen.2021.11.004. Epub 2021 Nov 15.
It is likely that additional genes for hereditary breast cancer can be identified using a discordant sib pair design. Using this design we identified individuals harboring a rare PMS1 c.605G>A variant previously predicted to result in loss of function.
A family-based design and predictive algorithms were used to prioritize candidate variants possibly associated with an increased risk of hereditary breast cancer. Functional analyses were performed for one of the candidate variants, PMS1 c.605G>A.
Genotype-phenotype correlation did not demonstrate tracking of the variant with cancer in the family. Functional analysis revealed no difference in exon 6 incorporation, which was validated by analyzing PMS1 allele specific expression.
The PMS1 c.605G>A variant did not segregate with disease, and there was no variant-dependent impact on PMS1 exon 6 splicing, supporting this variant is likely benign. Functional analyses are imperative to understanding the clinical significance of predictive algorithms.
使用不一致的同胞对设计,可能会鉴定出更多遗传性乳腺癌的基因。使用该设计,我们鉴定出了携带有先前预测导致功能丧失的罕见 PMS1 c.605G>A 变异的个体。
使用基于家族的设计和预测算法,优先考虑可能与遗传性乳腺癌风险增加相关的候选变异。对候选变异之一 PMS1 c.605G>A 进行了功能分析。
1)从遗传性乳腺癌家族中鉴定出 14 对不一致的姐妹对。2)进行全外显子组测序并鉴定候选风险变异。3)在 2 位无血缘关系的受影响姐妹中发现了罕见的 PMS 变异,但在无血缘关系的兄弟姐妹中没有发现。4)使用靶向 mRNA 测序对该变体进行功能分析。
基因型-表型相关性并未显示该变体与家族中癌症的关联性。功能分析显示,第 6 外显子的掺入没有差异,这通过分析 PMS1 等位基因特异性表达得到了验证。
PMS1 c.605G>A 变体与疾病没有分离,并且该变体对 PMS1 外显子 6 剪接没有影响,支持该变体可能是良性的。功能分析对于理解预测算法的临床意义至关重要。